What is Excellims?
Founded in 2005 and based in Acton, Massachusetts, Excellims is a key player in the manufacturing of chemicals and advanced instrumentation for ion mobility spectrometry (IMS). The company's product portfolio includes standalone IMS analyzers, ion mobility add-ons for mass spectrometers, and IMS detectors for liquid chromatography. These solutions are critical for precise chemical detection and quantification across various scientific and industrial applications.
How much funding has Excellims raised?
Excellims has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Excellims
PPP
Public-Private Partnership
What's next for Excellims?
With substantial capital raised, Excellims is positioned for significant expansion and further innovation in its specialized field. The large-scale, late-stage funding suggests a focus on scaling operations, enhancing its technological capabilities, and potentially broadening its market reach. This strategic investment will likely fuel advancements in ion mobility technology, reinforcing Excellims' competitive edge in providing sophisticated chemical analysis instrumentation.
See full Excellims company page
